Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J7186
    Short Description Antihemophilic viii/vwf comp
    Long Description Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.
    Pricing indicator 51
    Coverage code D
    ASC payment group code YY
    BETOS2 code O1E
    Action code N
    Type of service 1
    Effective date 2009-01-01
    Date Added 2009-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    68516461101 J7186 Antihemophilic viii/vwf comp Alphanate /von Willebrand Factor Complex GRIFOLS USA, LLC PER FACTOR VIII IU 1 1 1 1
    68516461201 J7186 Antihemophilic viii/vwf comp Alphanate /von Willebrand Factor Complex GRIFOLS USA, LLC PER FACTOR VIII IU 1 1 1 1
    68516461302 J7186 Antihemophilic viii/vwf comp Alphanate /von Willebrand Factor Complex GRIFOLS USA, LLC PER FACTOR VIII IU 1 1 1 1
    68516461402 J7186 Antihemophilic viii/vwf comp Alphanate /von Willebrand Factor Complex GRIFOLS USA, LLC PER FACTOR VIII IU 1 1 1 1
    68516461502 J7186 Antihemophilic viii/vwf comp Alphanate /von Willebrand Factor Complex GRIFOLS USA, LLC PER FACTOR VIII IU 1 1 1 1
    68516461601 J7186 Antihemophilic viii/vwf comp Alphanate /von Willebrand Factor Complex GRIFOLS BIOLOGICALS LLC PER FACTOR VIII IU 1 1 1 1
    68516461701 J7186 Antihemophilic viii/vwf comp Alphanate /von Willebrand Factor Complex GRIFOLS BIOLOGICALS LLC PER FACTOR VIII IU 1 1 1 1
    68516461802 J7186 Antihemophilic viii/vwf comp Alphanate /von Willebrand Factor Complex GRIFOLS BIOLOGICALS LLC PER FACTOR VIII IU 1 1 1 1
    68516461902 J7186 Antihemophilic viii/vwf comp Alphanate /von Willebrand Factor Complex GRIFOLS BIOLOGICALS LLC PER FACTOR VIII IU 1 1 1 1
    68516462002 J7186 Antihemophilic viii/vwf comp Alphanate /von Willebrand Factor Complex GRIFOLS BIOLOGICALS LLC PER FACTOR VIII IU 1 1 1 1
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].